News
-
-
PRESS RELEASE
Informations privilégiées / Autres communiqués
Innate Pharma reprend les droits sur l'ANKET ciblant CD123 et annonce l'intention de Sanofi de réaliser un investissement stratégique dans la société. Sanofi explorerait SAR'514/IPH6401 l'ANKET ciblant BCMA dans les indications auto-immunes -
-
-
-
PRESS RELEASE
Meyer Burger reacts to material shortages and introduces short-time work at the solar cell plant in Thalheim
Meyer Burger reacts to material shortages and introduces short-time work at the solar cell plant in Thalheim. Short-time work agreed with works council to save costs due to temporary material bottlenecks -
-
-
-